Premium
Prognostic impact of impaired left ventricular midwall function during progression of aortic stenosis
Author(s) -
Cramariuc Dana,
Bahlmann Edda,
Egstrup Kenneth,
Rossebø Anne B.,
Ray Simon,
Kesäniemi Yrjö Antero,
Nienaber Christoph A.,
Gerdts Eva
Publication year - 2021
Publication title -
echocardiography
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.404
H-Index - 62
eISSN - 1540-8175
pISSN - 0742-2822
DOI - 10.1111/echo.14916
Subject(s) - medicine , cardiology , asymptomatic , heart failure , ejection fraction , stenosis , left ventricular hypertrophy , population , blood pressure , proportional hazards model , environmental health
Objective In hypertension, indexes of midwall left ventricular (LV) function may identify patients at higher cardiovascular (CV) risk independent of normal LV ejection fraction (EF). We analyzed the association of baseline and new‐onset LV midwall dysfunction with CV outcome in a large population of patients with asymptomatic aortic stenosis (AS). Methods One thousand four hundred seventy‐eight patients with asymptomatic AS and normal EF (≥50%) at baseline in the Simvastatin Ezetimibe in Aortic Stenosis (SEAS) study were followed for a median of 4.3 years. LV systolic function was assessed by biplane EF and midwall shortening (MWS, low if <14% in men/16% in women) at baseline and annual echocardiographic examinations. Results One hundred twenty‐three CV deaths and heart failure hospitalizations occurred during follow‐up. In Cox analyses, adjusting for age, gender, body mass index, hypertension, EF, AS severity, LV hypertrophy and systemic arterial compliance, low baseline MWS predicted 61% higher risk of a major CV event and a twofold higher risk of death and heart failure hospitalization ( P < .05). New‐onset low MWS developed in 574 patients, particularly in elderly women with higher blood pressure and more severe AS ( P < .05). In time‐varying Cox analysis, new‐onset low MWS was associated with a twofold higher risk of CV death and heart failure hospitalization, independent of changes over time in EF, AS severity, LV hypertrophy and systemic arterial compliance ( P < .05). Conclusions Low MWS develops in a large proportion of patients with AS and normal EF during valve disease progression and is a marker of increased CV risk.